Compare MRVI & DCBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRVI | DCBO |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.8M | 489.9M |
| IPO Year | 2020 | 2020 |
| Metric | MRVI | DCBO |
|---|---|---|
| Price | $3.67 | $19.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | $4.57 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 1.1M | 270.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.29 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $185,743,000.00 | N/A |
| Revenue This Year | $11.80 | $12.54 |
| Revenue Next Year | $7.74 | $11.82 |
| P/E Ratio | ★ N/A | $22.04 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.67 | $16.07 |
| 52 Week High | $4.11 | $33.69 |
| Indicator | MRVI | DCBO |
|---|---|---|
| Relative Strength Index (RSI) | 62.09 | 54.98 |
| Support Level | $3.65 | $18.11 |
| Resistance Level | $4.03 | $20.15 |
| Average True Range (ATR) | 0.18 | 0.97 |
| MACD | 0.09 | 0.26 |
| Stochastic Oscillator | 78.64 | 86.72 |
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
Docebo Inc is a provider of cloud-based learning management systems. The solutions provided by the company allow learning administrators to deliver scalable and flexible personalized learning experiences, from formal training to social learning to multiple internal, external, and blended audiences. The group provides an easy-to-use, configurable, and affordable learning platform with the end-to-end capabilities and critical functionality needed to train both internal and external workforces, partners, and customers. The majority of the revenue is derived from customers based in North America.